Cytokeratin 6B Inhibitors

The chemical class of Cytokeratin 6B modulators primarily comprises compounds that indirectly influence the expression or function of KRT6B through various mechanisms. These include modulation of cell differentiation, proliferation, and gene expression regulation. The compounds listed are not direct inhibitors of KRT6B but can affect its expression or cellular context. Retinoids like Retinoic Acid, Tazarotene, and Bexarotene play a crucial role in skin health and disease, influencing keratinocyte differentiation and proliferation, which can indirectly affect keratin expression, including KRT6B. These agents are often used in dermatological conditions and can modulate the expression of various keratins by impacting cell differentiation pathways.

5-Fluorouracil, Methotrexate, and Cisplatin can influence keratinocyte proliferation and differentiation. These agents can have effects on keratin expression as part of their broader impact on rapidly dividing cells. Immunomodulatory drugs like Imiquimod and immunosuppressants such as Cyclosporine can alter keratinocyte behavior, which might impact KRT6B expression. These agents modulate the immune response and can influence skin cell dynamics. Histone deacetylase inhibitors like Vorinostat and bromodomain inhibitors such as JQ1 affect gene expression regulation. They have the capacity to modulate the expression of various proteins, including keratins, by altering chromatin structure and accessibility. Sirolimus, an mTOR inhibitor, affects cell growth and proliferation, which could have implications for keratin expression in certain cell types.